TRICARE Over-the-Counter Drug Demonstration Project, 66626-66627 [E9-29864]
Download as PDF
66626
Federal Register / Vol. 74, No. 240 / Wednesday, December 16, 2009 / Notices
Ordered, that the Settlement
Agreement be, and hereby is, accepted;
and it is Further ordered, that
Excelligence shall pay a civil penalty in
the amount of twenty five thousand
dollars ($25,000.00) within twenty (20)
calendar days of service of the
Commission’s final Order accepting the
Agreement. The payment shall be made
by check payable to the order of the
United States Treasury. Upon the failure
of Excelligence to make the foregoing
payment when due, interest on the
unpaid amount shall accrue and be paid
by Excelligence at the federal legal rate
Excelligence Learning Corporation
of interest set forth at 28 U.S.C. 1961(a)
Dated: 10–28–08
and (b).
By:
Provisionally accepted and
lllllllllllllllllllll
provisional Order issued on the 4th day
Kelly Crampton, Chief Executive Officer
of December 2009.
Excelligence Learning Corporation
modification, or alteration is sought to
be enforced.
26. If any provision of the Agreement
and Order is held to be illegal, invalid,
or unenforceable under present or future
laws effective during the terms of the
Agreement and Order, such provision
shall be fully severable. The balance of
the Agreement and Order shall remain
in full force and effect, unless the
Commission and Excelligence agree that
severing the provision materially affects
the purpose of the Agreement and
Order.
SUPPLEMENTARY INFORMATION:
Agenda
The Committee will meet to review
planned changes and progress in
developing computerized and paperand-pencil enlistment tests. The agenda
includes an overview of current
enlistment test development timelines
and planned research for the next three
years.
Public’s Accessibility to the Meeting
Pursuant to 5 U.S.C. 552b and 41 CFR
102–3.140 through 102–3.165, and the
availability of space, this meeting is
open to the public.
Oral Presentations/Written Statements
Persons desiring to make oral
presentations or submit written
statements for consideration at the
Committee meeting must contact Dr.
Jane M. Arabian (see FOR FURTHER
INFORMATION CONTACT) no later than
January 10, 2010.
d/b/a Discount School Supply
2 Lower Ragsdale Drive, Suite 200
Monterey, CA 93940
Dated: 10–27–08
By:
lllllllllllllllllllll
Jonathan I. Price, Esq.
Goodwin Procter LLP
The New York Times Building
620 Eighth Avenue
New York, NY 10018–1405
Counsel for Excelligence Learning
Corporation
By Order of the Commission:
lllllllllllllllllllll
Todd A. Stevenson, Secretary
U.S. Consumer Product Safety Commission
Defense Advisory Committee on
Military Personnel Testing; Meeting
BILLING CODE 5001–06–P
U.S. Consumer Product Safety Commission
Staff
Cheryl A. Falvey
General Counsel
Office of the General Counsel
Ronald G. Yelenik
Assistant General Counsel
Division of Compliance
Office of the General Counsel
Dated: 11–17–09
By:
lllllllllllllllllllll
M. Reza Malihi, Trial Attorney
Division of Compliance
Office of the General Counsel
AGENCY: Under Secretary of Defense for
Personnel and Readiness, DoD.
ACTION: Meeting notice.
DEPARTMENT OF DEFENSE
United States of America Consumer
Product Safety Commission
CPSC Docket No. 10–C0001
srobinson on DSKHWCL6B1PROD with NOTICES
In the Matter of: Excelligence Learning
Corporation D/B/A Discount School
Supply
Order
Upon consideration of the Settlement
Agreement entered into between
Excelligence Learning Corporation,
d/b/a Discount School Supply
(‘‘Excelligence’’) and the U.S. Consumer
Product Safety Commission
(‘‘Commission’’) staff, and the
Commission having jurisdiction over
the subject matter and over
Excelligence, and it appearing that the
Settlement Agreement and Order are in
the public interest, it is
VerDate Nov<24>2008
16:18 Dec 15, 2009
Jkt 220001
[FR Doc. E9–29943 Filed 12–15–09; 8:45 am]
BILLING CODE 6355–01–P
Dated: December 10, 2009.
Mitchell S. Bryman,
Alternate OSD Federal Register Liaison
Officer, Department of Defense.
[FR Doc. E9–29811 Filed 12–15–09; 8:45 am]
DEPARTMENT OF DEFENSE
Office of the Secretary
Under the provisions of the
Federal Advisory Committee Act of
1972 (5 U.S.C., Appendix, as amended),
the Government in the Sunshine Act of
1976 (5 U.S.C. 552b, as amended), and
41 CFR 102–3.150, DoD announces that
the Defense Advisory Committee on
Military Personnel Testing will meet on
January 21 and 22, 2010, to review
planned changes and progress in
developing computerized and paperand-pencil enlistment tests. Subject to
the availability of space, the meeting is
open to the public.
DATES: The meeting will be held on
January 21 (from 8:30 a.m. to 4 p.m.)
and January 22, 2010 (from 8:30 a.m. to
noon).
ADDRESSES: The meeting will be held at
The EPIC Hotel, 270 Biscayne Blvd.,
Miami, Florida 33131.
FOR FURTHER INFORMATION CONTACT:
Committee’s Designated Federal Officer
or Point of Contact: Dr. Jane M. Arabian,
Assistant Director, Accession Policy,
Office of the Under Secretary of Defense
(Personnel and Readiness), Room
2B271, The Pentagon, Washington, DC
20301–4000, telephone (703) 697–9271.
SUMMARY:
PO 00000
Frm 00013
Fmt 4703
Sfmt 4703
Office of the Secretary
TRICARE Over-the-Counter Drug
Demonstration Project
Office of the Secretary, DoD.
Notice of modifications and an
extension to the TRICARE over-thecounter drug demonstration project.
AGENCY:
ACTION:
SUMMARY: This notice is to advise
interested parties of modifications to
and an extension of the demonstration
project entitled ‘‘TRICARE Over-theCounter Drug Demonstration Project.’’
The original demonstration notice was
published on June 15, 2007 (72 FR
33208; FR Doc. E7–11558) and
described a demonstration project to
evaluate the costs/benefits and
beneficiary satisfaction of providing
OTC drugs under the pharmacy benefits
program when the selected OTC drugs
are determined to be clinically effective.
The demonstration was to be conducted
until the implementation of the
combined TRICARE mail and retail
contract (TPharm) which will be
November 4, 2009. This demonstration
project will now be modified and
extended for three additional years
(November 4, 2012).
E:\FR\FM\16DEN1.SGM
16DEN1
Federal Register / Vol. 74, No. 240 / Wednesday, December 16, 2009 / Notices
DATES: The modification and extension
of the demonstration project is effective
from November 4, 2009, to November 4,
2012.
FOR FURTHER INFORMATION CONTACT:
Colonel Everett McAllister, TRICARE
Management Activity, Pharmaceutical
Operations Directorate, telephone (703)
681–2890.
SUPPLEMENTARY INFORMATION:
A. Background
For additional information on the
TRICARE Over-the-Counter Drug
Demonstration Project, see 72 FR 33208
(June 15, 2007).
srobinson on DSKHWCL6B1PROD with NOTICES
B. Description of Modifications to the
Demonstration Project
(1) Paragraph B(2) of the original
notice at 72 FR 33209 is revised to read
as follows:
OTC drug availability through the
demonstration project. Eligible
candidates for the demonstration are
those who have a prescription for a
prescription item that has an approved
OTC drug equivalent, as defined by the
program. The process used to verify
eligibility will depend upon the
dispensing venue the beneficiary
chooses to use. Not all OTC drugs
eligible for dispensing through this
project will be available at all
dispensing venues. The Pharmacy
Program Office will communicate OTC
drug availability through the use of the
TRICARE Web site (https://
www.tricare.mil/pharmacy), public
affairs outreach, and through the
representative military beneficiary
organizations.
(2) Paragraph B(4) of the original
notice at 72 FR 33209 and 33210 is
revised to read as follows:
Cost sharing requirements. Until a
modification to the new pharmacy
contract software can occur to accept a
$0 cost share, beneficiaries will be
charged a non-reimbursable TRICARE
cost share of $3 identical to that charged
for a generic pharmaceutical agent. The
$3 cost share will apply until the earlier
of January 1, 2010 or the date on which
systems changes can be made to
accommodate processing of the retail
network pharmacy and mail order
pharmacy claims with a $0 cost share.
(3) Paragraph B(5) of the original
notice at 72 FR 33210 is revised to read
as follows:
Period of demonstration. The
modification of the demonstration
project will be effective November 4,
2009. This demonstration project will be
extended for three additional years
(November 4, 2012).
VerDate Nov<24>2008
16:18 Dec 15, 2009
Jkt 220001
Dated: December 11, 2009.
Mitchell S. Bryman,
Alternate OSD Federal Register Liaison
Officer, Department of Defense.
[FR Doc. E9–29864 Filed 12–15–09; 8:45 am]
BILLING CODE 5001–06–P
DEPARTMENT OF ENERGY
Federal Energy Regulatory
Commission
[Project No. 13596–000]
McGinnis, Inc.; Notice of Preliminary
Permit Application Accepted for Filing
and Soliciting Comments, Motions To
Intervene, and Competing Applications
December 10, 2009.
On September 29, 2009, McGinnis,
Inc. filed an application for a
preliminary permit, pursuant to section
4(f) of the Federal Power Act, proposing
to study the feasibility of the Smithland
Hydrokinetic Project, which would be
located downstream of the U.S. Army
Corps of Engineer’s Smithland Lock and
Dam on the Ohio River near the town
of Hamletsburg, Pope County, Illinois;
and town of Smithland, Livingston
County, Kentucky. The sole purpose of
a preliminary permit, if issued, is to
grant the permit holder priority to file
a license application during the permit
term. A preliminary permit does not
authorize the permit holder to perform
any land disturbing activities or
otherwise enter upon lands or waters
owned by others without the owners’
express permission.
The proposed project would consist of
the following:
(1) Ten 35-kilowatt turbine generators
mounted to a barge anchored in the
Ohio River downstream of the
Smithland Lock and Dam; (2) an
armored transmission cable extending
from the barge to a small shore
substation; and (3) an access road
needed to access the shore substation.
The project would have an estimated
annual generation of 1,533,000 kilowatthours.
Applicant Contact: Mr. Bruce D.
McGinnis, Sr.; McGinnis, Inc.; P.O. Box
534; 502 Second St. Ext.; South Point,
OH 45680; or phone 740–377–4391.
FERC Contact: Monte TerHaar at
monte.terhaar@ferc.gov or phone 202–
502–6035.
Deadline for filing comments, motions
to intervene, competing applications
(without notices of intent), or notices of
intent to file competing applications: 60
days from the issuance of this notice.
Comments, motions to intervene,
notices of intent, and competing
PO 00000
Frm 00014
Fmt 4703
Sfmt 4703
66627
applications may be filed electronically
via the Internet. See 18 CFR
385.2001(a)(1)(iii) and the instructions
on the Commission’s Web site (https://
www.ferc.gov/docs-filing/ferconline.asp)
under the ‘‘eFiling’’ link. For a simpler
method of submitting text only
comments, click on ‘‘Quick Comment.’’
For assistance, please contact FERC
Online Support at
FERCOnlineSupport@ferc.gov; call tollfree at (866) 208–3676; or, for TTY,
contact (202) 502–8659. Although the
Commission strongly encourages
electronic filing, documents may also be
paper-filed. To paper-file, mail an
original and eight copies to: Kimberly D.
Bose, Secretary, Federal Energy
Regulatory Commission, 888 First
Street, NE., Washington, DC 20426.
More information about this project,
including a copy of the application, can
be viewed or printed on the ‘‘eLibrary’’
link of Commission’s Web site at
https://www.ferc.gov/docs-filing/
elibrary.asp. Enter the docket number
(P–13596) in the docket number field to
access the document. For assistance,
contact FERC Online Support.
Kimberly D. Bose,
Secretary.
[FR Doc. E9–29916 Filed 12–15–09; 8:45 am]
BILLING CODE 6717–01–P
DEPARTMENT OF ENERGY
Federal Energy Regulatory
Commission
[Project No. 13513–000]
Lock+ Hydro Friends Fund XXII, LLC;
Notice of Preliminary Permit
Application Accepted for Filing and
Soliciting Comments, Motions To
Intervene, and Competing Applications
December 10, 2009.
On June 12, 2009, Lock+ Hydro
Friends Fund XXII, LLC filed an
application for a preliminary permit,
pursuant to section 4(f) of the Federal
Power Act, proposing to study the
feasibility of the Project Darwin, which
would be located at the U.S. Army
Corps of Engineer’s Cape Fear Lock and
Dam No. 1 on the Cape fear River near
the town of Kings Bluff, Bladen County,
NC. The sole purpose of a preliminary
permit, if issued, is to grant the permit
holder priority to file a license
application during the permit term. A
preliminary permit does not authorize
the permit holder to perform any land
disturbing activities or otherwise enter
upon lands or waters owned by others
without the owners’ express permission.
E:\FR\FM\16DEN1.SGM
16DEN1
Agencies
[Federal Register Volume 74, Number 240 (Wednesday, December 16, 2009)]
[Notices]
[Pages 66626-66627]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-29864]
-----------------------------------------------------------------------
DEPARTMENT OF DEFENSE
Office of the Secretary
TRICARE Over-the-Counter Drug Demonstration Project
AGENCY: Office of the Secretary, DoD.
ACTION: Notice of modifications and an extension to the TRICARE over-
the-counter drug demonstration project.
-----------------------------------------------------------------------
SUMMARY: This notice is to advise interested parties of modifications
to and an extension of the demonstration project entitled ``TRICARE
Over-the-Counter Drug Demonstration Project.'' The original
demonstration notice was published on June 15, 2007 (72 FR 33208; FR
Doc. E7-11558) and described a demonstration project to evaluate the
costs/benefits and beneficiary satisfaction of providing OTC drugs
under the pharmacy benefits program when the selected OTC drugs are
determined to be clinically effective. The demonstration was to be
conducted until the implementation of the combined TRICARE mail and
retail contract (TPharm) which will be November 4, 2009. This
demonstration project will now be modified and extended for three
additional years (November 4, 2012).
[[Page 66627]]
DATES: The modification and extension of the demonstration project is
effective from November 4, 2009, to November 4, 2012.
FOR FURTHER INFORMATION CONTACT: Colonel Everett McAllister, TRICARE
Management Activity, Pharmaceutical Operations Directorate, telephone
(703) 681-2890.
SUPPLEMENTARY INFORMATION:
A. Background
For additional information on the TRICARE Over-the-Counter Drug
Demonstration Project, see 72 FR 33208 (June 15, 2007).
B. Description of Modifications to the Demonstration Project
(1) Paragraph B(2) of the original notice at 72 FR 33209 is revised
to read as follows:
OTC drug availability through the demonstration project. Eligible
candidates for the demonstration are those who have a prescription for
a prescription item that has an approved OTC drug equivalent, as
defined by the program. The process used to verify eligibility will
depend upon the dispensing venue the beneficiary chooses to use. Not
all OTC drugs eligible for dispensing through this project will be
available at all dispensing venues. The Pharmacy Program Office will
communicate OTC drug availability through the use of the TRICARE Web
site (https://www.tricare.mil/pharmacy), public affairs outreach, and
through the representative military beneficiary organizations.
(2) Paragraph B(4) of the original notice at 72 FR 33209 and 33210
is revised to read as follows:
Cost sharing requirements. Until a modification to the new pharmacy
contract software can occur to accept a $0 cost share, beneficiaries
will be charged a non-reimbursable TRICARE cost share of $3 identical
to that charged for a generic pharmaceutical agent. The $3 cost share
will apply until the earlier of January 1, 2010 or the date on which
systems changes can be made to accommodate processing of the retail
network pharmacy and mail order pharmacy claims with a $0 cost share.
(3) Paragraph B(5) of the original notice at 72 FR 33210 is revised
to read as follows:
Period of demonstration. The modification of the demonstration
project will be effective November 4, 2009. This demonstration project
will be extended for three additional years (November 4, 2012).
Dated: December 11, 2009.
Mitchell S. Bryman,
Alternate OSD Federal Register Liaison Officer, Department of Defense.
[FR Doc. E9-29864 Filed 12-15-09; 8:45 am]
BILLING CODE 5001-06-P